Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients
- PMID: 37041799
- PMCID: PMC10083009
- DOI: 10.2147/IJGM.S402212
Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients
Abstract
Background: Procoagulant microvesicles (MVs) are submicron membrane fragments released from activated cells and cells undergoing apoptosis. The procoagulant activity of MVs is enhanced in the presence of tissue factor (TF). MVs and TF are active mediators that induce pro-inflammatory response and prothrombotic tendency and have been linked to the severity of several disorders, including malaria infection. The current study aimed to measure the levels of circulating procoagulant MVs and TF-bearing MVs in malaria patients and correlate these levels with other hematological parameters and parasitemia.
Materials and methods: Levels of MVs and TF-bearing MVs in the plasma of children and adult patients infected with Plasmodium falciparum were measured alongside matched healthy controls.
Results: Patients with Plasmodium falciparum infection had ~3.8 times MVs (p < 0.0001) and ~13.0 times TF-bearing MVs compared to the matched healthy controls. MVs showed inverse significant correlation with platelet count (p = 0.0055), hemoglobin (p = 0.0004) and parasitemia.
Conclusion: Elevated levels of MVs and TF-bearing MVs could be useful biomarkers to evaluate the procoagulant activity, inflammatory response and parasitemia levels in malaria infection, aiding in better management of the disease.
Keywords: malaria; microvesicles; procoagulant; prothrombotic inflammation; tissue factor.
© 2023 Madkhali et al.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.Infect Drug Resist. 2022 Apr 29;15:2359-2368. doi: 10.2147/IDR.S355395. eCollection 2022. Infect Drug Resist. 2022. PMID: 35517897 Free PMC article.
-
IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets.Thromb Haemost. 2017 Jun 28;117(7):1379-1390. doi: 10.1160/TH16-10-0784. Epub 2017 May 11. Thromb Haemost. 2017. PMID: 28492698
-
Evaluation of circulating microvesicles and their procoagulant activity in patients with COVID-19.BMC Res Notes. 2024 Aug 22;17(1):233. doi: 10.1186/s13104-024-06875-9. BMC Res Notes. 2024. PMID: 39175048 Free PMC article.
-
Microvesicles as risk markers for venous thrombosis.Expert Rev Hematol. 2013 Feb;6(1):91-101. doi: 10.1586/ehm.12.74. Expert Rev Hematol. 2013. PMID: 23373784 Review.
-
Microvesicles and Cancer Associated Thrombosis.Semin Thromb Hemost. 2019 Sep;45(6):593-603. doi: 10.1055/s-0039-1693476. Epub 2019 Aug 20. Semin Thromb Hemost. 2019. PMID: 31430786 Review.
Cited by
-
An Assessment of Endothelial Markers in Patients with Uncomplicated Malaria in Jazan Province, Saudi Arabia.Int J Gen Med. 2025 Jun 7;18:2949-2956. doi: 10.2147/IJGM.S513929. eCollection 2025. Int J Gen Med. 2025. PMID: 40502331 Free PMC article.
-
Engineered Extracellular Vesicles in Chronic Kidney Diseases: A Comprehensive Review.Int J Nanomedicine. 2024 Mar 7;19:2377-2393. doi: 10.2147/IJN.S452393. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38469058 Free PMC article. Review.
-
Challenges with measuring tissue factor antigen and activity in human plasma.Blood Vessel Thromb Hemost. 2024 Jul 31;1(4):100022. doi: 10.1016/j.bvth.2024.100022. eCollection 2024 Dec. Blood Vessel Thromb Hemost. 2024. PMID: 40765933 Free PMC article. Review.
References
-
- World Health Organization. World malaria report 2021; 2021. Available from: https://www.who.int/publications/i/item/9789240040496. Accessed March 31, 2023.
LinkOut - more resources
Full Text Sources
Miscellaneous